Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Kenvue Inc. (KVUE : NYSE)

• Company Description    Kenvue Inc. is a pure-play consumer health company. Its brand portfolio includes AVEENO(R), BAND-AID(R) Brand Adhesive Bandages, JOHNSON'S(R), LISTERINE(R), NEUTROGENA(R), TYLENOL(R) and ZYRTEC(R). Kenvue Inc. is based in SKILLMAN, N.J. Number of Employees: 22,000

• Price / Volume Information    Yesterday's Closing Price: $18.88 Daily Weekly Monthly 20 Day Moving Average: 58,429,080 shares Shares Outstanding: 1,915.98 (millions) Market Capitalization: $36,173.79 (millions) Beta: 0.59 52 Week High: $25.17 52 Week Low: $14.02 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 8.63% 8.54% 12 Week 9.64% 8.55% Year To Date 9.45% 8.88%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1 KENVUE WAY - SUMMIT,NJ 07901 USA ph: 908-874-1200 fax: - kenvue_ir@kenvue.com http://www.kenvue.com

• General Corporate Information    Officers Thibaut Mongon - Chief Executive Officer and Director Larry J. Merlo - Chair of the Board Paul Ruh - Chief Financial Officer Richard E. Allison - Director Tamara S. Franklin - Director Peer Information Kenvue Inc. (EPC) Kenvue Inc. (HPPS) Kenvue Inc. (ADRNY) Kenvue Inc. (YHGJ) Kenvue Inc. (GPSYY) Kenvue Inc. (HENKY) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: CONS PD- MISC STPL Sector: Consumer Staples CUSIP: 49177J102 SIC: 2844 Fiscal Year Fiscal Year End: December Last Reported Quarter: 12/01/25 Next Expected EPS Date: 05/14/26 Share - Related Items Shares Outstanding: 1,915.98 Most Recent Split Date: (:1) Beta: 0.59 Market Capitalization: $36,173.79 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 4.40% Current Fiscal Quarter EPS Consensus Estimate: $0.26 Indicated Annual Dividend: $0.83 Current Fiscal Year EPS Consensus Estimate: $1.09 Payout Ratio: 0.78 Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 02/11/2026 - $0.21 Next EPS Report Date: 05/14/26

• Fundamental Ratios P/E Current FY Estimate: 17.27 Trailing 12 Months: 17.48 PEG Ratio: - Price Ratios Price/Book: 3.40 Price/Cash Flow: 12.83 Price / Sales: 2.39 EPS Growth vs. Year Ago Period: 3.85% vs. Previous Quarter: -3.57% Sales Growth vs. Year Ago Period: 3.22% vs. Previous Quarter: 0.43% ROE 12/31/25 - 19.86 09/30/25 - 20.02 06/30/25 - 20.06 ROA 12/31/25 - 7.74 09/30/25 - 7.74 06/30/25 - 7.78 Current Ratio 12/31/25 - - 09/30/25 - 0.98 06/30/25 - 0.98 Quick Ratio 12/31/25 - - 09/30/25 - 0.69 06/30/25 - 0.68 Operating Margin 12/31/25 - 13.75 09/30/25 - 13.70 06/30/25 - 13.61 Net Margin 12/31/25 - 9.72 09/30/25 - 9.55 06/30/25 - 9.37 Pre-Tax Margin 12/31/25 - 13.22 09/30/25 - 12.78 06/30/25 - 13.00 Book Value 12/31/25 - - 09/30/25 - 5.55 06/30/25 - 5.59 Inventory Turnover 12/31/25 - 3.62 09/30/25 - 3.67 06/30/25 - 3.70 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.66 06/30/25 - 0.66 Debt-to-Capital 12/31/25 - - 09/30/25 - 39.90 06/30/25 - 39.67

Powered by Zacks Investment Research ©